ARID1A and ovarian carcinoma: Not surprisingly, this synthetic lethality relationship appears to be absent in certain subtypes of cancers harboring ARID1A mutations, such as endometrial/uterine cancer, pancreatic cancer, ovarian cancer, lung cancer and colon cancer (Figure 3).